RecruitingNot ApplicableNCT03513731

Safety of Adipose-derived Regenerative Cells Injection for Treatment of Osteoarthritis of the Facet Joint

Safety and Efficacy of Injection of Adipose-derived Regenerative Cells (ADRCs) in Patients Suffering From Osteoarthritis of the Facet Joints

Sponsor

InGeneron, Inc.

Enrollment

40 participants

Start Date

Dec 7, 2018

Study Type

INTERVENTIONAL

Conditions

Osteoarthritis of Facet Joint of Lumbar Spine

Summary

This is a prospective, randomized, active controlled, single site safety and efficacy study in subjects suffering from chronic lumber back pain due to facet joint osteoarthritis comparing a single ADRC injection generated with the Transpose® RT system into the facet joint.

Eligibility

Min Age: 18 YearsMax Age: 75 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a medical device called Adipose-derived stem cell injection and a drug called Corticosteroid injection for people with osteoarthritis of facet joint of lumbar spine. The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years to 75 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEAdipose-derived stem cell injection

ADRC injection into the facet joint

DRUGCorticosteroid injection

Corticosteroid injection into the facet joint

Locations(2)

Sports and Orthopedic Center

Deerfield Beach, Florida, United States

Sanford Physical Medicine & Rehabilitation Clinic and Sanford Spine Center

Sioux Falls, South Dakota, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT03513731